Objective: The objective of our study was to retrospectively determine whether minimal fat renal angiomyolipoma can be differentiated from clear cell or papillary renal cell carcinoma (RCC) in small renal masses using attenuation measurement histogram analysis on unenhanced CT.
Materials And Methods: Twenty minimal fat renal angiomyolipomas were compared with 22 clear cell RCCs and 23 papillary RCCs using an institutional database. All masses were histologically confirmed and all minimal fat renal angiomyolipomas lacked radiographic evidence of macroscopic fat. Using attenuation measurement histogram analysis, two blinded radiologists determined the percentage of negative pixels within each renal mass. The percentages of negative pixels below attenuation thresholds of 0, -5, -10, -15, -20, -25, and -30 HU were recorded. Sensitivity, specificity, positive predictive value, negative predictive value, and receiver operator characteristic curves for the diagnosis of minimal fat renal angiomyolipoma were generated for each threshold. The Student t test was used to compare radiologists and cohorts. Previously published attenuation and pixel-counting thresholds reported as having a specificity of near 100% for discriminating between minimal fat renal angiomyolipomas and RCCs were analyzed.
Results: The mean maximal transverse lesion diameter was 1.8 cm for minimal fat renal angiomyolipomas (SD, 0.5 cm; range, 1.1-3.0 cm), 2.1 cm for clear cell RCCs (SD, 0.5 cm; range, 1.0-2.9 cm), and 2.1 cm for papillary RCCs (SD, 0.7 cm; range, 1.3-3.9 cm). No significant difference in the percentage of negative pixels was found between minimal fat renal angiomyolipomas and clear cell RCCs or between minimal fat renal angiomyolipomas and papillary RCCs at any of the selected attenuation thresholds for either radiologist (p = 0.210-0.499). Radiologist 1 and radiologist 2 used significantly different region-of-interest sizes (p < 0.001), but neither radiologist could differentiate minimal fat renal angiomyolipoma from RCC. No previously published threshold allowed discrimination between minimal fat renal angiomyolipoma and RCC with 100% specificity.
Conclusion: Attenuation measurement histogram analysis cannot reliably differentiate minimal fat renal angiomyolipoma from RCC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2214/AJR.11.6887 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Randomized Pilot Study of Time-Restricted Eating Shows Minimal Microbiome Changes.
Nutrients
January 2025
Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Objective: TRE is an emerging approach in obesity treatment, yet there is limited data on how it influences gut microbiome composition in humans. Our objective was to characterize the gut microbiome of human participants before and after a TRE intervention. This is a secondary analysis of a previously published clinical trial examining the effects of time-restricted eating (TRE).
View Article and Find Full Text PDFEpigenetic Modulation with 5-Aza-CdR Prevents Metabolic-Associated Fatty Liver Disease Promoted by Maternal Overnutrition.
Nutrients
December 2024
Department of Nutrition, Texas A&M University, College Station, TX 77843, USA.
Background/objectives: This study builds on previous findings from mouse models, which showed that maternal overnutrition induced by a high-fat diet (HFD) promotes metabolic-associated fatty liver disease (MAFLD) in offspring, linked to global DNA hypermethylation. We explored whether epigenetic modulation with 5-Aza-CdR, a DNA methylation inhibitor, could prevent MAFLD in offspring exposed to maternal overnutrition.
Methods: The offspring mice from dams of maternal overnutrition were fed either a chow diet or a high-fat diet (HFD) for 10 weeks.
Minimum Wrestling Weight for High School Girls Wrestling: Time to Revisit Minimal Body Fat Percent.
J Strength Cond Res
January 2025
School of Sport, Recreation and Tourism Management, George Mason University, Fairfax, Virginia.
Jagim, AR, Horswill, CA, Dobbs, WC, Twohey, EE, Tinsley, GM, Fields, JB, and Jones, MT. Minimum wrestling weight for high school girls wrestling: Time to revisit minimal body fat percent. J Strength Cond Res XX(X): 000-000, 2024-The purpose of this study was to determine whether an alternative body fat percentage (BF%) could be established as a safer margin for minimal wrestling weight (MWW) determination by evaluating the distribution of BF% and MWW values naturally occurring for high school girls wrestling.
View Article and Find Full Text PDFCarbohydrate Ingestion Eliminates Hypoglycemia & Improves Endurance Exercise Performance in Triathletes Adapted to Very Low & High Carbohydrate Isocaloric Diets.
Am J Physiol Cell Physiol
January 2025
Sansum Diabetes Research Institute, Santa Barbara, CA, USA.
Very-low-carbohydrate diets (LCHF; <50g/day) have been debated for their potential to lower pre-exercise muscle and liver glycogen stores and metabolic efficiency, risking premature fatigue. It is also hypothesized that carbohydrate ingestion during prolonged exercise delays fatigue by increasing carbohydrate oxidation, thereby sparing muscle glycogen. Leveraging a randomized crossover design, we evaluated performance during strenuous time-to-exhaustion (70%⩒O) tests in trained triathletes following 6-week high-carbohydrate (HCLF, 380g/day) or very-low-carbohydrate (LCHF, 40g/day) diets to determine (i) if adoption of the LCHF diet impairs time-to-exhaustion performance, (ii) whether carbohydrate ingestion (10g/hour) 6-12x lower than current CHO fuelling recommendations during low glycogen availability (>15-hour pre-exercise overnight fast and/or LCHF diet) improves time-to-exhaustion by preventing exercise-induced hypoglycemia (EIH; <3.
View Article and Find Full Text PDFA Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled-Release Formulations Versus a Marketed Orlistat Product.
Clin Pharmacol Drug Dev
January 2025
Empros Pharma AB, Solna, Sweden.
A new modified-release oral formulation combines acarbose and orlistat (MR-OA) to enhance efficacy and reduce adverse effects through controlled drug release. This study aims to compare the pharmacodynamic properties of the orlistat component of MR-OA (MR-O) with a conventional orlistat product, Xenical (Conv-O), analyzing the percentage of fecal fat excretion. In addition, the pharmacokinetic properties of the complete formulation, MR-OA, were compared with Conv-O.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!